Skip to main content
Clinical Trials/NCT06713031
NCT06713031
Not Yet Recruiting
N/A

Prospective, Multicenter, Randomized Controlled Clinical Study of Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures

Chinese PLA General Hospital1 site in 1 country400 target enrollmentDecember 10, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Fracture of Neck of Femur
Sponsor
Chinese PLA General Hospital
Enrollment
400
Locations
1
Primary Endpoint
Fracture healing rate
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

A prospective, multi-center, randomized controlled study was conducted to validate the safety and effectiveness of employing the medial augmentation technique (incorporating the dynamic condylar screw and medial support plate) supplemented with bone grafting for the treatment of old femoral neck fractures.

Registry
clinicaltrials.gov
Start Date
December 10, 2024
End Date
October 31, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Chinese PLA General Hospital
Responsible Party
Principal Investigator
Principal Investigator

Zhang Wei

Deputy head of orthopedics

Chinese PLA General Hospital

Eligibility Criteria

Inclusion Criteria

  • Age \>= 18 years, gender not specified;
  • Patients with femoral neck fractures who have not undergone surgery for more than 3 weeks, or patients with persistent non-union following internal fixation of femoral neck fractures;
  • Have indications for internal fixation surgery for femoral neck fractures and are able to tolerate the surgery;
  • Participants or their legal representatives are informed about the nature of this study and agree to participate.

Exclusion Criteria

  • Participants who have not reached the primary endpoint of other drug, biological agent, or medical device clinical trials prior to enrollment;
  • Known history of hypersensitivity to one or more implanted materials by the patient;
  • Judged by the investigator as physically frail or unable to tolerate surgery due to other systemic diseases;
  • Active infectious foci in the hip joint or other parts of the body, as judged by the investigator;
  • Diagnosed with metabolic bone disease, radiation-induced bone disease, etc.;
  • Severe hip contracture deformity or severe muscle weakness that has been immobilized in functional position for a long time and painless;
  • Suffering from inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.;
  • Patients who lack the mental capacity or understanding to meet the requirements of participating in the study, or are difficult to cooperate with;
  • Other situations where the investigator deems the participant unsuitable for inclusion.

Outcomes

Primary Outcomes

Fracture healing rate

Time Frame: 1 year

Secondary Outcomes

  • Femoral head necrosis(1 year)
  • Harris score(1 year)
  • VAS score(1 year)
  • Complications(1 year)

Study Sites (1)

Loading locations...

Similar Trials